Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness

BACKGROUND & AIMS: Hepatitis C virus (HCV) eradication with direct-acting antivirals (DAAs) reduces but does not eliminate the risk for hepatocellular carcinoma (HCC). The development of surveillance strategies for HCC after the sustained virologic response (SVR) is therefore warranted. We aimed...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JHEP Rep
Hlavní autoři: Dajti, Elton, Marasco, Giovanni, Ravaioli, Federico, Colecchia, Luigi, Ferrarese, Alberto, Festi, Davide, Colecchia, Antonio
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Short Communication
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8165428/
https://ncbi.nlm.nih.gov/pubmed/34095798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100289
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky